Advances in the Diagnosis and Management of Rheumatic Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 4138
Special Issue Editor
Special Issue Information
Dear Colleagues,
Systemic autoimmune diseases are a group of heterogeneous diseases driven by autoimmune pathogenesis. The treatment of autoimmune diseases with a “treat to target” strategy was established in 2009. The principle of treat-to-target involves several steps, including target identification, initiation of medication and achievement of disease activity score. All of these require accurate and effective biomarkers. For rheumatoid arthritis, rheumatoid factor (RF) and anti-CCP antibody aid in accurate diagnosis. ESR and CRP can evaluate disease activity. Recently, precise therapy referred to as personalized medicine has been a hot topic in the field. Even though we have many powerful biologics or tsDMARDs for the management of autoimmune diseases, we are still unable to accurately predict the outcomes of these medications.
Therefore, research on advanced biomarkers for predicting the efficacy of targeted therapy is most important. Hence, all research regarding advances in biomarkers of the efficacy of targeted therapies are welcome in this Special Issue. We warmly invite you and your colleagues to submit all types of articles—original research articles, comprehensive and critical reviews, and even letters—given the expansive interest of this area.
Dr. Wennan Huang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
